¼±ÐÔÁÜ°Íϸ°û°×Ѫ²¡ÊÇÔõô»ØÊ µÃÁ˼±ÐÔÁÜ°Íϸ°û°×Ѫ²¡Ôõô°ì ±±¾©ÖÎÁƼ±ÐÔÁÜ°Íϸ°û°×Ѫ²¡ºÃ²»ºÃ
¶ÔÓÚÁÜ°Íĸϸ°ûÁö´ó¼ÒÒ»¶¨ÊǺÜÄ°ÉúµÄ£¬ÒòΪһ°ãÇé¿ö϶¼ÊǶÔÓÚÖ×ÁöÊÇÓÐÈÏʶµÄ¡£µ«ÊÇÒòΪÁÜ°Íĸϸ°ûÁö»¹ÊDZȽÏÉÙ¼ûµÃ¼²²¡£¬ËùÒÔ´ó¼Ò¶ÔÓÚÕâ¸ö¼²²¡ÖªµÀ»¹ÊDZȽÏÉٵģ¬Õâ¸öʱºò¹ØÓÚÕâ¸ö¼²²¡Ò»Ð©Ö¢×´ºÍÖÎÁÆʲôµÄ»¹ÊÇ»á¶à¶àÉÙÉÙµÄÓÐЩ²»Ì«ÈÏʶ£¬Ôì³ÉÁËһЩÎÊÌâ³öÏÖ¡£ÄÇô£¬ÁÜ°Íĸϸ°ûÁö¾ßÌåÊÇÔõô»ØÊÂ?
¶ÔÓÚÁÜ°Íĸϸ°ûÁö´ó¼ÒÒ»¶¨ÊǺÜÄ°ÉúµÄ£¬ÒòΪһ°ãÇé¿ö϶¼ÊǶÔÓÚÖ×ÁöÊÇÓÐÈÏʶµÄ¡£µ«ÊÇÒòΪÁÜ°Íĸϸ°ûÁö»¹ÊDZȽÏÉÙ¼ûµÃ¼²²¡£¬ËùÒÔ´ó¼Ò¶ÔÓÚÕâ¸ö¼²²¡ÖªµÀ»¹ÊDZȽÏÉٵģ¬Õâ¸öʱºò¹ØÓÚÕâ¸ö¼²²¡Ò»Ð©Ö¢×´ºÍÖÎÁÆʲôµÄ»¹ÊÇ»á¶à¶àÉÙÉÙµÄÓÐЩ²»Ì«ÈÏʶ£¬Ôì³ÉÁËһЩÎÊÌâ³öÏÖ¡£ÄÇô£¬ÁÜ°Íĸϸ°ûÁö¾ßÌåÊÇÔõô»ØÊÂ?
ÁÜ°Íĸϸ°ûÁö¾ßÌåÊÇÔõô»ØÊÂ(1)
ÁÜ°Íĸϸ°ûÁÜ°ÍÁö( lymphoblastic lymphoma,LBL)ΪǰÌåÁÜ°Íϸ°ûÀ´Ô´µÄ¸ßÇÖÏ®ÐÔ·Ç»ôÆæ½ðÁÜ°ÍÁö(non-Hodgkin’s lymphoma,NHL),ÓÉÓÚÁÜ°Íĸϸ°ûÁÜ°ÍÁöÓë¼±ÐÔÁÜ°Íϸ°û°×Ѫ²¡(acute lymphoblastic leukemia,ALL)ÔÚϸ°ûÐÎ̬ѧ¡¢ÃâÒß±íÐÍ¡¢»ùÒòÐÍ¡¢Ï¸°ûÒÅ´«Ñ§µÈÉúÎïѧÌØÕ÷¼°ÁÙ´²±íÏÖºÍÔ¤ºóÏàËÆ,WHOзÖÀཫÁÜ°Íĸϸ°ûÁÜ°ÍÁöºÍ¼±ÐÔÁÜ°Íϸ°û°×Ѫ²¡¹éΪͬһ×é¼²²¡¡£
ÁÙ´²±íÏÖ£ºÁÜ°Íĸϸ°ûÁÜ°ÍÁöÒÔÇàÉÙÄêÄÐÐÔ¶à¼û,ÓÐ×ݸôռλ»ò°é¾±²¿ÁܰͽáÖ×´óÕßÓ¦¿¼ÂÇÁÜ°Íĸϸ°ûÁÜ°ÍÁö¿ÉÄÜ¡£ÁÜ°Íĸϸ°ûÁÜ°ÍÁö80%ΪTϸ°ûÆðÔ´£¬20%ΪBϸ°ûÆðÔ´¡£¼±ÐÔÁÜ°Íϸ°û°×Ѫ²¡80%ΪBϸ°ûÆðÔ´£¬20%ΪTϸ°ûÆðÔ´¡£TÁÜ°Íĸϸ°ûÐÔÁÜ°ÍÁöÊÇ—ÖÖ·Ç»ôÆæÁÜ°ÍÁöµÄÉÙ¼ûÀàÐÍ£¬»¼Õ߶àΪ¶ùͯ(>10Ëê)ºÍÇàÄê(<30Ëê)£¬ÄÐÐԾӶࡣ³£ÇÖ·¸×ݸô¡¢¹ÇËè¡¢ÖÐÊàºÍÁܰͽᡣÁÙ´²Í¨³£ÎªIII»òIVÆڵĽøÕ¹ÆÚ±íÏÖ£¬²¡³Ì¶Ì£¬½øչѸËÙ£¬Ô¤ºó²î£¬²¡³ÌÔçÆÚÒ×·¢Éú¹ÇËèÇÖ·¸£¬²¢Ò×ת»¯ÎªT¼±ÐÔÁÜ°Íĸϸ°û°×Ѫ²¡¡£BÁÜ°Íĸϸ°ûÐÔÁÜ°ÍÁö³£ÇÖ·¸¹Ç¡¢Æ¤·ô¡¢¹ÇËèºÍÁܰͽᡣ
Õï¶Ï£º²¡ÀíÕï¶ÏÌص㣺¿ÉÓÐÐÇ¿ÕÏÖÏ󣬺˷ÖÁÑÃ÷ÏÔ¡£ T ÁÜ°Íĸ£ºsIg-¡¢CD10-¡¢CD19/CD20-¡¢CD3-/+¡¢CD4/8+/+¡¢CD1a+/-¡¢TdT+¡¢CD2+¡¢CD7+¡£B ÁÜ°Íĸ£ºsIg-¡¢CD10+¡¢CD19+¡¢CD20-/+¡¢TdT+¡£TdTÒõÐÔ²»ÄÜÍêÈ«ÅųýLBLÕï¶Ï¡£ ÖÎÁÆ£ºÖÎÁÆÔÔòÒÔ»¯ÁÆΪÖ÷£¬¼Ó¾Ö²¿·ÅÉäÖÎÁÆ¡£¶ÔIII»òIVÆÚ»¼Õß²ÉÓÃÓë°×Ѫ²¡Ò»ÑùµÄÖÎÁÆ·½°¸¡£¾ßÌåÖÎÁÆ·½°¸ÒÀ¾ÝÔ·¢²¿Î»¡¢ÊÜÇÖ·¶Î§¡¢ÁÙ´²·ÖÆÚ¶ø²»Í¬¡£²ÉÓÃCOMP»òCHOP·½°¸ÖÎÁÆЧ¹û½Ï²î£¬½ö»ñµÃ30~40%µÄ³¤ÆÚÉú´æÂÊ¡£TÁÜ°Íĸϸ°ûÁÜ°ÍÁöÉúÎïѧÌØÐÔÓë¼±ÐÔÁÜ°Íϸ°û°×Ѫ²¡ÏàËÆ£¬ÖÎÁÆÉϳ£²ÉÓü±ÐÔÁÜ°Íϸ°û°×Ѫ²¡µÄ·½°¸¡£
ÓÉÓÚÁÜ°ÍϵͳµÄÌØÊâÔÒò£¬ËùÒÔ˵¹ØÓÚÁÜ°Íĸϸ°ûÁö»¹ÊǶÔÓÚÉíÌåµÄÓ°Ïì±È½Ï´óµÄ¡£Ò»¿ªÊ¼²»Ì«Á˽âÕâ¸ö¼²²¡µÄ»¼Õßͨ¹ýÉÏÎĵĽéÉܺóÒ²Ó¦¸ÃÊÇÓÐÁ˺ܴóµÄÈÏʶÁË¡£²»ÂÛÊÇʲô¼²²¡Á˽âÇå³þ£¬ÈÏÕæµÄ¶Ô´ýºÍ¸ù¾ÝÒ½ÉúµÄÖ¸µ¼²ÅÄܸüºÃµÄÖÎÓúÉíÌ彡¿µ